Fatty Liver Program
Nonalcoholic fatty liver disease is the most common liver disease in the U.S., affecting as much as 25% of the population. The Cedars-Sinai Fatty Liver Program provides advanced diagnosis, treatment and ongoing research to protect your liver and your health.
What Is Nonalcoholic Fatty Liver Disease?
Nonalcoholic fatty liver disease (NAFLD) happens when there is a buildup of fat in the liver, often due to excess weight. Too much fat in the liver can lead to inflammation, swelling and damage (a condition called nonalcoholic steatohepatitis or NASH). NAFLD can result in cirrhosis, or scarring of the liver, which can be life-threatening. However, with proper treatment, you can relieve symptoms and avoid complications.
Our Approach to Fatty Liver Disease
At Cedars-Sinai, we provide:
A Team of Specialists
Our liver specialists work with nutritionists, physical therapists and weight loss experts (both surgical and nonsurgical). We work together to get you the care you need at every stage of fatty liver disease. Meet our expert team.
Advanced Noninvasive Testing
Cedars-Sinai uses state-of-the-art diagnostic equipment, such as liver fat fraction and elastography measurements, to reduce the risk of complications from traditional liver biopsy.
Our team provides prompt, accurate diagnosis of nonalcoholic fatty liver disease, NASH and cirrhosis. When you need answers, we help you get them.
We work with you to find the best treatment for you, whether that means participating in a weight-loss, exercise program, medications, clinical trials or having liver transplant surgery.
Diagnosis & Treatment
Our nationally recognized fatty liver disease experts diagnose and treat all stages of nonalcoholic fatty liver, nonalcoholic steatohepatitis and cirrhosis. We can help you adopt lifestyle changes to manage nonalcoholic fatty liver disease and improve your overall health.
We are dedicated to finding innovative ways to quickly and accurately diagnose and treat fatty liver disease. Our ongoing clinical trials offer access to the newest treatments for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and cirrhosis.
Nonalcoholic Fatty Liver Research
Researchers at Cedars-Sinai are continually studying new treatments for nonalcoholic fatty liver disease.
While there are currently no medications for NAFLD or NASH, we are testing the effects of S-adenosylmethionine (SAMe). SAMe is a natural compound found in our bodies, and it may play a role in reducing liver inflammation that results from these conditions.
We are studying the role of microbiome in NAFLD and NASH. Microbiome include bacteria and fungi that are eliminated by the stool.